Summary
GlobalData's clinical trial report, “Viral Bronchiolitis Global Clinical Trials Review, H2, 2018" provides an overview of Viral Bronchiolitis clinical trials scenario. This report provides top line data relating to the clinical trials on Viral Bronchiolitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Pharmed Ltd
Hotel Dieu Hospital
Hamad Medical Corp
F. Hoffmann-La Roche Ltd
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Viral Bronchiolitis to Respiratory Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Viral Bronchiolitis to Respiratory Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Viral Bronchiolitis Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profile Snapshots 28
Appendix 40
Abbreviations 40
Definitions 40
Research Methodology 41
Secondary Research 41
About GlobalData 41
Contact Us 42
Source 42
List of Tables
Viral Bronchiolitis Therapeutics, Global, Clinical Trials by Region, 2018* 7
Viral Bronchiolitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Viral Bronchiolitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Viral Bronchiolitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11
Viral Bronchiolitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Viral Bronchiolitis Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Viral Bronchiolitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Viral Bronchiolitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Viral Bronchiolitis to Respiratory Clinical Trials, G7 Countries (%), 2018* 16
Viral Bronchiolitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Viral Bronchiolitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Viral Bronchiolitis to Respiratory Clinical Trials, E7 Countries (%), 2018* 19
Viral Bronchiolitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Viral Bronchiolitis Therapeutics, Global, Clinical Trials by Phase, 2018* 21
Viral Bronchiolitis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22
Viral Bronchiolitis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23
Viral Bronchiolitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 24
Viral Bronchiolitis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 25
Viral Bronchiolitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 26
Viral Bronchiolitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 27
List of Figures
Viral Bronchiolitis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Viral Bronchiolitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Viral Bronchiolitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Viral Bronchiolitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 11
Viral Bronchiolitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Viral Bronchiolitis Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Viral Bronchiolitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Proportion of Viral Bronchiolitis to Respiratory Clinical Trials, G7 Countries (%), 2018* 16
Viral Bronchiolitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Viral Bronchiolitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Viral Bronchiolitis to Respiratory Clinical Trials, E7 Countries (%), 2018* 19
Viral Bronchiolitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Viral Bronchiolitis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
Viral Bronchiolitis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22
Viral Bronchiolitis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23
Viral Bronchiolitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 24
Viral Bronchiolitis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 25
Viral Bronchiolitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 26
Viral Bronchiolitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 27
GlobalData Methodology 41
